A recent report from Stat News indicates a decrease in federal lobbying efforts by cannabis industry operators. Notably, Curaleaf, a significant player in the industry, reduced its lobbying spending in Washington, D.C., by almost 40% during the first half of the year compared to its peak spending in 2019. Furthermore, both Columbia Care and Pax Labs took more drastic measures by eliminating their lobbying teams.
High Times sent Ethan Zohn across the country during the World Cup to find where…
When most people think about the FIFA World Cup, they think about moments. The winning…
As younger consumers rethink their relationship with alcohol, retailers like SWADE Cannabis are betting cannabis…
Pepper’s drummer reflects on Point Break Festival, reggae-rock’s traveling family, growing up around Hawaiian cannabis,…
The hearing that could decide weed’s federal future starts June 29. The DEA invited seven…
Robinhood is a popular US-based investment app that allows everyday individuals to buy and sell…